Dr. Cervantez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407
Summary
- Dr. Sherri Cervantez is an oncologist in San Antonio, TX and is affiliated with multiple hospitals in the area, including University Health / UT Health Science Center at San Antonio and University Health / UT Health Science Center at San Antonio. She received her medical degree from Virginia Commonwealth University School of Medicine and has been in practice 7 years. She specializes in head & neck cancer, hospice & palliative, and thoracic cancer.
Education & Training
- Virginia Commonwealth University Health SystemFellowship, Hospice and Palliative Medicine, 2013 - 2014
- West Virginia UniversityResidency, Internal Medicine, 2010 - 2013
- Virginia Commonwealth University School of MedicineClass of 2010
Certifications & Licensure
- TX State Medical License 2017 - 2026
- VA State Medical License 2013 - 2018
- WV State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Comprehensive care for patients with hepatocellular carcinoma: insights from the 2022 San Antonio Liver Cancer Symposium.Sukeshi Patel Arora, Sherri Rauenzahn Cervantez
Annals of Palliative Medicine. 2024-07-01 - Pilot study evaluating feasibility and utility of pharmacist-driven oral antineoplastic agent monitoring program.Stefan M Allen, Sherri R Cervantez, Bradi L Frei, Jim M Koeller
Journal of Oncology Pharmacy Practice. 2024-03-01 - 1 citationsHypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report.Shreya Tripathy, Nathaniel Alvarez, Shubham Jaiswal, Ryan Williams, Munaf Al-Khadimi
Journal of Medical Case Reports. 2022-11-25
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: